VSNL1 and Alzheimer disease: These findings were later confirmed, showing that VILIP-1 levels correlate with the rate of cognitive decline in patients with AD, and that the VILIP-1/Aβ42 ratio has a diagnostic value comparable to that of t-Tau and p-Tau181 [88].